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Background: The number of transplant patients of childbearing age has increased. Decisions regard-
ing the pregnancy management are challenging. Close monitoring includes screening for complica-
tions including rejection, graft dysfunction, and infection. First pregnancy in a post-cardiac trans-
plant patient was reported in 1988 in a female patient who conceived less than 2 years post-transplant. 
Since then, there are many case reports that have demonstrated successful pregnancies in solid organ 
transplant recipients.1-3
Case report: We present a case of 42-years-old female patient who underwent heart transplant 2016. 
In 2018 the patient expressed wishes for pregnancy and childbirth. A multidisciplinary team of cardi-
ologists and gynecologists was formed and preconception and genetic counseling given. Before preg-
nancy we adjusted standard immunosuppressant therapy – mycophenolate mofetil was excluded, 
prednisone was continued in dose of 5 mg daily, and tacrolimus titrated to achieve concentration of 
10-15 ng/ml. One month later, myocardial biopsy excluded graft rejection and 6 months later patient 
conceived naturally. Graft function was assessed by regular monthly NT-proBNP check. Echocardiog-
raphy performed at 4th and 35th week of pregnancy showed normal graft function. In 36th week of preg-
nancy patient was admitted to our Department due to renal failure and hyperkalemia and was treated 
conservatively. Due to labor contractions on the 7th day of hospitalization, urgent caesarean section 
was performed in general anesthesia. Our patient gave birth to a healthy male newborn, without post-
partal complications. Standard immunosuppressant therapy with mycophenolate mofetil, tacrolimus 
and prednisone was introduced immediately after birth. Repeated myocardial biopsy performed in the 
follow-up showed no signs of graft rejection. 
Conclusion: Pregnancy and childbirth in post-cardiac transplant patient is feasible and should be 
managed by multidisciplinary team of healthcare providers. 
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